Article Sidebar
Published:
Jul 20, 2021Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Antiproliferative and proapoptotic activities of ferulic acid in breast and liver cancer cell lines
Abstract
Purpose: To explore the potential anticancer activities of ferulic acid (4-hydroxy-3-methoxycinnamic acid, FA) on two different human cancers cell lines, viz, breast (MCF-7) and hepatocellular (HepG2).
Methods: MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cytotoxicity, Annexin V staining, enzyme-linked immunosorbent assay (ELISA), as well as caspase-8 and -9 activation assays were used to evaluate the proapoptotic and antiproliferative potentials of ferulic acid (FA) on MCF-7 and HepG2 cell lines.
Results: Ferulic acid exerted cytotoxic effects on MCF-7 and HepG2 cell lines with half-maximal inhibitory concentration (IC50) of 75.4 and 81.38 μg/mL, respectively, at 48 h. Annexin V staining revealed evidence of apoptosis. Caspase-8 and-9 levels were elevated in both cell lines after incubation with ferulic acid.
Conclusion: The findings of this study suggest that ferulic acid has promising therapeutic potentials for the treatment of breast and liver cancers by inducing apoptosis via activation of caspase-8 and -9 pathways.
